Alkermes plc. (ALKS)

SEC filing

Alkermes plc.

ALKS · CIK 1520262

4 · Sep 1, 2026 · EVP R&D, Chief Medical Officer Hopkinson Craig C. sold 9,000 shares at $46.99/share ($422.9K); exercised options for 10K shares

EVP R&D, Chief Medical Officer Hopkinson Craig C. sold 9,000 shares at $46.99/share ($422.9K); exercised options for 10K shares

PRIMARY DOCUMENT

xslF345X06/form4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).